Aurobindo Pharma Subsidiary Gets One Observation During A Us Fda Inspection Of The Tirupati Plant

Top Stories

Company

L&T Partners with PS Technology to Revolutionise Railways

6 mins read. August 2, 2024 at 12:45 PM

Company

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr

4 mins read. August 2, 2024 at 12:41 PM

Company

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr

4 mins read. August 2, 2024 at 12:36 PM

Stock chart

Aurobindo Pharma subsidiary gets one observation during a US FDA inspection of the Tirupati plant

ri-calendar-2-lineSep 20, 2023

By: BlinkX Research Team

FbkFbkTwitterTelegram

APL Healthcare Limited, a subsidiary of Aurobindo Pharma, has received a 'Form 483' with one observation from the US Food and Drug Administration for its Unit IV factory in Tirupati District, Andhra Pradesh, the company informed stock exchanges on September 20.

 

The inspection took place from September 13 to September 19, 2023.

 

The company stated in a press statement that the 'Form 483', which was issued with one observation, is of a procedural nature. When the US FDA observes any lapses during a facility inspection, it issues a Form 483. The companies are then directed to establish corrective action plans to address the issues.

 

According to analysts, the least important concern for companies is procedural observation. Quality or data integrity issues are of greater concern and can result in significant regulatory action.

 

Aurobindo Pharma stated that it will respond to the US FDA within the timeframes specified and will work closely with the US FDA to close the observation as soon as possible.

Related News

News Thumbnail
Company

L&T Partners with PS Technology to Revolutionise Railways

6 mins read. August 2, 2024 at 12:45 PM

News Thumbnail
Company

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr

4 mins read. August 2, 2024 at 12:41 PM

News Thumbnail
Company

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr

4 mins read. August 2, 2024 at 12:36 PM

News Thumbnail
Company

NBCC Arm Gets Two Construction Projects Worth Rs 443.61 Cr

4 mins read. August 2, 2024 at 12:33 PM

Related Blogs

Stock chartDemat Account

Biggest Winners and Losers in MSCI: Key Movers in Global Indices 2025

0 people read

3 mins read . Aug 20, 2025

Stock chartMutual Fund

What MF Big Boys Bought and Sold – Top Mutual Fund Stock Activity in 2025

0 people read

8 mins read . Aug 18, 2025

Download app

Access BlinkX
everywhere
across device

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions